50
Participants
Start Date
February 1, 2022
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
Tocilizumab
Tocilizumab is a recombinant humanized monoclonal antibody directed against the human interleukin-6 (IL-6) receptor
NOT_YET_RECRUITING
Complejo Hospitalario Universitario A Coruña, A Coruña
ACTIVE_NOT_RECRUITING
Hospital del Mar, Barcelona
NOT_YET_RECRUITING
Marqués de Valdecilla Research Institute, Santander
NOT_YET_RECRUITING
Hospital Universitario Dr. Peset, Valencia
RECRUITING
Transplant Center, Sahlgrenska University Hospital, Gothenburg
RECRUITING
Skåne University Hospital, Malmo
RECRUITING
Karolinksa University Hospital, Stockholm
RECRUITING
Uppsala University Hospital, Uppsala
Karolinska University Hospital
OTHER
Uppsala University Hospital
OTHER
Skane University Hospital
OTHER
The Swedish Research Council
OTHER_GOV
Hospital del Mar
OTHER
Hospital Universitario Doctor Peset
OTHER
Complexo Hospitalario Universitario de A Coruña
OTHER
Hospital Universitario Marqués de Valdecilla
OTHER
Vastra Gotaland Region
OTHER_GOV